Search Results - "Gaboriau, L."

Hemorrhagic bullous dermatosis (HBD): A rare side-effect of heparins by Gérard, A, Levavasseur, M, Gaboriau, L, Stichelbout, M, Staumont-Salle, D

“…Bullous haemorrhagic dermatosis (BHD) induced by heparin is a rare and benign side effect of which we report two cases. Case 1: an 81-year-old man presented…”
Get full text

Aripiprazole: A new risk factor for pathological gambling? A report of 8 case reports by Gaboriau, L, Victorri-Vigneau, C, Gérardin, M, Allain-Veyrac, G, Jolliet-Evin, P, Grall-Bronnec, M

“…Abstract Objective It is commonly accepted that pathological gambling results from the interaction of multiple risk factors. Among these, dopamine replacement…”
Get full text

P11.52.A Peripheral neuropathies after BRAF and/or MEK inhibitors treatment: a pharmacovigilance study by Picca, A, Birzu, C, Berzero, G, Sanchez-Pena, P, Gaboriau, L, Vidil, F, Lenglet, T, Tafani, C, Ricard, D, Psimaras, D, Bihan, K

“…Abstract Background BRAF (BRAFi) and MEK inhibitors (MEKi) demonstrated significant efficacy in the treatment of BRAF-activated tumours, firstly melanoma…”
Get full text

Naltrexone- or Nalmefene-Related Buprenorphine Withdrawal: Treat It With… More Buprenorphine by Lescut, Charles, Gaboriau, Louise, Carton, Louise, Rolland, Benjamin

Get full text

Meningoradiculitis due to varicella zoster virus reactivation in a patient treated with ixekizumab by Dubois, M., Morel, G., Tone, A., Gaboriau, L., Gautier, S., Lazrek, M., Vermersch-Langlin, A.

“…Ixekizumab is a recently developed biopharmaceutical used since 2016 in the US and Europe for the treatment of plaque psoriasis. Few adverse effects have been…”
Get full text

Serious adverse drug reactions with sacubitril/valsartan Entresto(R): a French pharmacovigilance survey: Eur J Clin Pharmacol by Moulis, F., Rousseau, V., Chebane, L., Gouverneur, Amandine, Gaboriau, L., Faillie, J. L., Durrieu, G., Montastruc, F., Montastruc, J. L.

Get full text

Bisphosphonate-related osteonecrosis of the jaw: data from the French national pharmacovigilance database by de Boissieu, Paul, Gaboriau, Louise, Morel, Aurore, Trenque, Thierry

“…The aim of this study was to describe bisphosphonate‐related osteonecrosis of the jaw (BRONJ) in the French national pharmacovigilance database. BRONJ was…”
Get full text

5PSQ-014 Impact of histamine-2 antagonist shortage on the incidence of hypersensitivity reactions to paclitaxel – towards crisis management and a premedication reconsideration in France (PACLIREACT Study) by Strobbe, G, Gaboriau, L, Abele, M, Villain, A, Aelbrecht-Meurisse, C, Carnot, A, Le Deley, MC, Léguillette, C, Sakji, I, Feutry, F, Marliot, G

“…Background and ImportanceAt the beginning of October 2019, an international shortage of ranitidine forced us to adjust paclitaxel-based chemotherapy…”
Get full text

The drugs that most frequently induce acute kidney injury: a case-noncase study of pharmacovigilance database by Pierson-Marchandise, M., Gras, Valérie, Moragny, J., Micallef, J., Gaboriau, L., Picard, S., Choukroun, Gabriel, Masmoudi, K., Liabeuf, Sophie

Get full text

Dermatose bulleuse hémorragique (DBH) : un effet indésirable rare des héparines by Gérard, A., Levavasseur, M., Gaboriau, L., Stichelbout, M., Staumont-Salle, D.

“…La dermatose bulleuse hémorragique (DBH) induite par l’héparine est un effet indésirable rare et bénin dont nous rapportons deux cas. Cas 1 : un homme de…”
Get full text

Survenue de maladies inflammatoires chroniques de l’intestin de novo nn anti-interleukine 17 : une éventualité rare - résultats finaux de l’étude cas-témoins MISSIL by Letarouilly, J.G., Pariente, B., Pham, T., Pierache, A., Acquacalda, E., Banneville, B., Barbarot, S., Baudart, P., Bauer, E., Claudepierre, P., Constantin, A., Dernis, E., Felten, R., Gaudin, P., Girard, C., Gombert, B., Goupille, P., Guennoc, X., Henry Desailly, I., Jullien, D., Karimova, E., Lanot, S., Le, D.L., Pascart, T., Plastaras, L., Sultan-Bichat, N., Truchet, X., Varin, S., Wendling, D., Gaboriau, L., Staumont-Sallé, D., Peyrin-Biroulet, L., Flipo, R.M.

“…La question de la survenue de maladies inflammatoires chroniques de l’intestin (MICI) de novo (MICI-DN) sous inhibiteurs de l’interleukine 17 (anti-IL 17) a…”
Get full text

Meningoradiculitis due to varicella zoster virus reactivation in a patient treated with ixekizumab by Dubois, M, Morel, G, Tone, A, Gaboriau, L, Gautier, S, Lazrek, M, Vermersch-Langlin, A

“…INTRODUCTIONIxekizumab is a recently developed biopharmaceutical used since 2016 in the US and Europe for the treatment of plaque psoriasis. Few adverse…”
Get full text